• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Sanofi

Research highlights cost savings from DarioHealth digital diabetes therapeutic

July 26, 2023 By Sean Whooley

DarioHealth (Nasdaq:DRIO) announced today that a new analysis demonstrated a significant cost reduction for users of its digital therapeutic platform. Sanofi U.S. conducted the analysis, which showed lower costs of care for DarioHealth users compared to non-users with type 2 diabetes. The study used matched claims to show an estimated $5,077 in medical cost savings […]

Filed Under: Clinical Trials, Diabetes, Digital Health, Health Technology, Software / IT Tagged With: DarioHealth Corp, Sanofi

Glooko, Sanofi partner on insulin pen connectivity

February 23, 2023 By Sean Whooley

Glooko announced today that it entered into a partnership with Sanofi to integrate a connected device for insulin pens into its digital platform. SoloSmart, a single-piece, add-on connected device works with Sanofi’s SoloStar and DoubleStar insulin injection pens. It records the insulin dose, date and time of injection. Through this partnership, the company’s can offer […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Drug-Device Combinations, Health Technology, Patient Monitoring, Software / IT Tagged With: Glooko, Sanofi

Sanofi unveils new campus in Massachusetts

June 7, 2022 By Chris Newmarker

Sanofi announced today that it is officially opening its new 900,000-square-foot campus at Cambridge Crossing in Cambridge, Massachusetts. The new campus brings together 2,500 Sanofi Massachusetts-based employees in a shared space. The goal is to improve collaboration between R&D, Medical, and the Specialty Care business unit — and grow a science-centered, patient-focused culture. The Paris-based […]

Filed Under: Business/Financial News, Featured, News Well, Research & Development Tagged With: Massachusetts, Sanofi

Digital therapeutics open up new opportunities in medicine

May 5, 2022 By Sean Whooley

A wide range of companies are aiming to make waves through digital therapeutic offerings, and each is doing things differently. “We are seeing tremendous momentum for the DTx industry, with more and more products coming to market and gaining commercial coverage and recent signals from the White House and Congress demonstrating their interest and recognition […]

Filed Under: Business/Financial News, Digital Health, Health Technology, Neurological, Software / IT Tagged With: Better Therapeutics, DarioHealth Corp, Digital therapeutics, Pear Therapeutics, Sanofi

Sanofi details €2B plan to make France an mRNA leader

March 9, 2022 By Brian Buntz

French drugmaker Sanofi (Nasdaq:SNY) said it would spend €935 million (about $1.1 billion) between 2022 and 2026 to produce mRNA-based vaccines. That funding is part of a larger €2 billion (about $2.4 billion) initiative to accelerate its mRNA development capability, Sanofi explained on its French-language website. The company plans to use the funds to ramp […]

Filed Under: News Well, Pharmaceutical Tagged With: mRNA vaccines, mRNA-based vaccines, Sanofi

Gyroscope Therapeutics to receive investment from Sanofi worth up to $60M

November 8, 2021 By Sean Whooley

Gyroscope Therapeutics announced today that it received a commitment from Sanofi (NYSE:SNY) to invest up to $60 million. London-based Gyroscope will receive a $40 million investment from Sanofi initially. That $40 million represents a premium to Gyroscope’s previous Series C financing, with the remaining $20 million to be invested contingent on a future qualifying investment round and other certain […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Funding Roundup, Optical/Ophthalmic, Pharmaceutical Tagged With: Gyroscope Therapeutics, Sanofi

Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

November 5, 2021 By Sean Whooley

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Baxter, Boston Scientific, GE Healthcare, Grail, Hillrom, Illumina Inc., Medtronic, PerkinElmer Inc., Philips, Roche, Sanofi, Siemens Healthineers, Thermo Fisher Scientific, Varian Medical Systems, Vectura

Sanofi to acquire Kadmon for $1.9B

September 8, 2021 By Sean Whooley

Sanofi (NYSE:SNY) announced today that it entered into a definitive merger with therapeutic developer Kadmon (NSDQ:KDMN) for $1.9 billion. The acquisition adds Rezurock (belumosudil), a recently FDA-approved, first-in-class treatment for chronic graft-versus-host disease (cGVHD) for patients over 12 years old who have failed at least two prior lines of systemic therapy, to Sanofi’s transplant portfolio. Get the full […]

Filed Under: Business/Financial News, Drug-Device Combinations, Mergers & Acquisitions Tagged With: kadmon, Sanofi

Sanofi to spend nearly half a billion dollars a year on mRNA vaccine research

June 29, 2021 By Sean Whooley

Sanofi (NYSE:SNY) announced today that it plans to invest approximately $476.3 million (€400 million) per year on mRNA vaccine development. Paris-based Sanofi’s intends for its annual investment to go toward a first-of-its-kind vaccine “mRNA Center of Excellence” to accelerate the development and delivery of next-generation vaccines. Get the full story at our sister site, Drug […]

Filed Under: Business/Financial News, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, mRNA vaccines, Sanofi

Pharma 50: Here’s how the world’s largest pharma companies are doing

May 12, 2021 By Chris Newmarker

The global pharmaceutical industry held up well during the pandemic, with 10 of the largest businesses only seeing a roughly –3% drop in revenue in 2020. Eight of the 10 even came out ahead. That’s one of the big takeaways from our sister publication Drug Discovery & Development’s inaugural Pharma 50, a compilation of data […]

Filed Under: Business/Financial News, Featured, Pharmaceutical Tagged With: AstraZeneca, Gilead Sciences, GlaxoSmithKline plc, Janssen Pharmaceuticals, Johnson & Johnson, Merck, Novartis, Pfizer, Pharma 50, Roche, Sanofi, Sinopharm

Bigfoot Biomedical wins FDA clearance for smart insulin pen cap system

May 10, 2021 By Sean Whooley

Bigfoot Biomedical announced today that it received FDA 510(k) clearance for its Bigfoot Unity diabetes management system. Milpitas, Calif.-based Bigfoot’s first-of-its-kind Bigfoot Unity system features connected smart pen caps designed to recommend insulin doses for diabetes patients using multiple daily injection (MDI) therapy, according to a news release. Get the full story at our sister site, […]

Filed Under: 510(k), Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Abbott, Bigfoot Biomedical, Eli Lilly & Co., FDA, Novo Nordisk, Sanofi

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy